North West Cancer Research Trading Limited
08280650
Some Concerns
- No accounts filed in last 18 months (-5)
Details
Compliance
Last accounts
30/09/2024
small
Next accounts due
30/06/2026
Confirmation statement
Last: 22/10/2025
Due 05/11/2026
Industry
Officers
secretary · Since 20/04/2017
director · Since 04/11/2022
IT CONSULTANT
BRITISH · WALES · Age 44
Also on 2 other boards
director · Since 04/11/2022
MANAGING DIRECTOR
BRITISH · ENGLAND · Age 48
Also on 3 other boards
director · Since 04/11/2022
FINANCE PROFESSIONAL
BRITISH · NETHERLANDS · Age 54
director · Since 22/08/2025
DIRECTOR OF MARKETING CONSULTANCY
BRITISH · UNITED KINGDOM · Age 63
Also on 5 other boards
Persons with Significant Control
North West Cancer Research (Incorporating Clatterbridge Cancer Research "Ccr")
North West Cancer Research Centre, 200 London Road, Liverpool, L3 9TA
Reg: 02165552 · England And Wales · Private Company Limited By Guarantee Exempt Under Section 60
Notified 06/04/2016
CompanyRankvs 1671+ SIC 47799 peers37
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2023
Net Worth
£1
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£0
Working capital
Current Assets
—
Current Liabilities
£0
Balance Sheet